CHRNA7 and Alzheimer disease: Other studies showed that acetylcholinesterase inhibitor galantamine (one of a few approved AD medications) sensitizes microglial α7 nAChRs to choline and induces Ca2+ influx into microglia, resulting in upregulation of Ca2+-dependent amyloid β phagocytosis [130].